ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

SLDB Solid Biosciences Inc

10,10
-0,13 (-1,27%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Solid Biosciences Inc SLDB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,13 -1,27% 10,10 06:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
10,33 10,02 10,70 10,10 10,23
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
03.4.202422:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
01.4.202413:45GLOBESolid Biosciences Receives Rare Pediatric Disease..
27.3.202412:00GLOBESolid Biosciences to Participate at Cantor’s Virtual..
13.3.202412:44GLOBESolid Biosciences Provides Fourth Quarter and Full-Year 2023..
07.3.202413:00GLOBESolid Biosciences Announces Licensing Agreement with Armatus..
06.3.202414:00GLOBESolid Biosciences to Participate at Upcoming Investor..
16.2.202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202417:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
30.1.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
16.1.202414:50DJNSolid Biosciences Gets Orphan Drug Designation for SGT-003
16.1.202414:00GLOBESolid Biosciences Granted FDA Orphan Drug Designation for..
12.1.202423:05EDGAR2Form SC 13D/A - General statement of acquisition of..
11.1.202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:31EDGAR2Form SC 13D/A - General statement of acquisition of..
08.1.202413:24EDGAR2Form 8-K - Current report
08.1.202413:09GLOBESolid Biosciences Announces $109 Million Private Placement
06.1.202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202414:00GLOBESolid Biosciences to Participate at 42nd Annual J.P. Morgan..
07.12.202316:49DJNSolid Biosciences Shares Jump After FDA Fast-Tracks SGT-0003
07.12.202314:00GLOBESolid Biosciences Receives FDA Fast Track Designation for..
05.12.202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202314:00GLOBESolid Biosciences to Participate at 35th Annual Piper..
15.11.202314:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
15.11.202313:59EDGAR2Form 8-K - Current report
14.11.202322:05GLOBESolid Biosciences Announces IND Clearance by FDA for..
09.11.202314:00GLOBESolid Biosciences to Participate at Jefferies London..
08.11.202322:17GLOBESolid Biosciences Provides Third Quarter Business Update and..
08.11.202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20.10.202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202322:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
02.10.202314:00GLOBESolid Biosciences Appoints Gabriel Brooks, M.D., as Chief..
20.9.202314:00GLOBESolid Biosciences to Participate at Upcoming Investor..
06.9.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202314:56GLOBESolid Biosciences to Participate at Upcoming Investor..
31.8.202314:00GLOBESolid Biosciences to Participate in Citi’s 18th Annual..
14.8.202322:17GLOBESolid Biosciences Provides Second Quarter Business Update..
14.8.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.6.202314:00GLOBESolid Biosciences to Participate at the Jefferies Healthcare..
22.5.202314:00GLOBESolid Biosciences to Participate at the Barclays Gene..
16.5.202314:00GLOBESolid Biosciences to Present at the American Society of Gene..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock